3,990
-0.99%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Ray Co
Its shares trade on KOSDAQ under the ticker 228670.KQ. It has been listed since 8 August 2019. In the fiscal year to 31 December 2025, it reported revenue of ₩111.32bn and net income of ₩3.14bn. At that date it held total assets of ₩192.24bn and shareholders' equity of ₩76.50bn.
Ray Co., Ltd. engages in the manufacture and sale of advanced technology medical devices. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2019-08-08. Along with its subsidiaries, the Company manufactures and sells digital diagnostic systems and digital therapy solution products. Digital diagnostic systems include dental radiography equipments such as x-ray systems and cone beam computed tomography (CBCT) systems. Digital therapy solutions include three dimensional (3D) scanning, dental computer aided design (CAD), and 3D printers used in prosthodontics, orthodontics, and implant surgery. The firm distributes its products within domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 8 Aug 2019
- Website
- raymedical.co.kr ↗
Leadership
Pay as last reported
- Mr. Sang Cheol LeeChief Executive Officer, Director
- Wu Seok SongVice President, Director
- Mr. Cheol Wu JungAssistant Managing Director
- Mr. Jae Hyeon KimAssistant Managing Director
- Si Yeong YangInternal Auditor
- Chang Hwan ByunDirector
- Sang Hu KimDirector
- Yo Han KimDirector
- Mr. Seong Wu JungNon-Executive Independent Director
- Mr. Chung Geun ParkNon-Executive Independent Director
- Gil Bae ParkNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Ray Co Ltd manufactures dental radiography equipment including x-ray systems and cone beam computed tomography (CBCT) systems.
- The company distributes digital diagnostic systems and digital therapy solutions within the domestic market in South Korea.
- Ray Co Ltd has an IPO listing date of August 2019, providing access to public capital markets.
Weaknesses
- Ray Co Ltd operates only in the Health Care sector with no diversification into other industries.
- The company's product line is limited to dental medical devices such as x-ray systems and 3D printers.
- Ray Co Ltd has a single headquarters city of Hwaseong, South Korea, with no mention of international offices.
Opportunities
- Ray Co Ltd can expand its digital therapy solutions into overseas markets beyond the domestic South Korean market.
- The company can leverage its digital diagnostic systems for new applications in dental care.
- Ray Co Ltd may grow its product range by developing additional medical device solutions.
Threats
- Ray Co Ltd faces competition from other medical device manufacturers in the South Korean market.
- The company's reliance on dental medical devices could be threatened by regulatory changes in the Health Care sector.
- Ray Co Ltd's domestic market focus may limit growth potential compared to competitors with broader international presence.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.